You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

esophagogastric cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophagogastric Cancer Trial in New York (Survey, Intra-oral camera)

Recruiting
  • Esophagogastric Cancer
  • Survey
  • Intra-oral camera
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Dec 28, 2022

Esophagogastric Cancer Trial in Toronto (PET-MRI)

Recruiting
  • Esophagogastric Cancer
  • PET-MRI
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 5, 2023

Esophagogastric Cancer Trial in United States (Amivantamab)

Recruiting
  • Esophagogastric Cancer
  • Boston, Massachusetts
  • +7 more
Oct 24, 2022

Esophagogastric Cancer, HER2-Negative Trial in United States (regorafenib, nivolumab, FOLFOX chemo with oxaliplatin)

Active, not recruiting
  • Esophagogastric Cancer
  • HER2-Negative
  • Basking Ridge, New Jersey
  • +6 more
Nov 23, 2022

Esophagogastric Cancer, Moderate to Severe Dysphagia Trial in New York, Re?ovot (WST 11-mediated VTP therapy)

Active, not recruiting
  • Esophagogastric Cancer
  • Moderate to Severe Dysphagia
  • WST 11-mediated VTP therapy
  • New York, New York
  • +1 more
Oct 25, 2022

Esophagogastric Cancer Trial in New York (89Zr-DFO-trastuzumab, PET imaging)

Active, not recruiting
  • Esophagogastric Cancer
  • 89Zr-DFO-trastuzumab
  • PET imaging
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 7, 2021

Esophageal Cancer, Gastric Adenocarcinoma, HER2 Gene Mutation Trial in United States (Pembrolizumab, Trastuzumab)

Not yet recruiting
  • Esophageal Cancer
  • +2 more
  • Baltimore, Maryland
  • +8 more
Nov 3, 2023

Epiphora Due to Insufficient Drainage, Left Side, Epiphora Due to Insufficient Drainage, Right Side Trial in Tianjin

Recruiting
  • Epiphora Due to Insufficient Drainage, Left Side
  • Epiphora Due to Insufficient Drainage, Right Side
  • Esophagogastric Side to Side Anastomosis
  • Esophagogastric End to Side Anastomosis
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Apr 2, 2023

Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in Netherlands (Capecitabine, Oxaliplatin, Retifanlimab)

Recruiting
  • Gastric Adenocarcinoma
  • Esophageal Adenocarcinoma
  • Amsterdam, Netherlands
  • +7 more
Jan 31, 2022

GLIM-defined Malnutrition Criteria for Postoperative Outcomes in

Completed
  • Cancer of Stomach
  • +3 more
  • no intervention
  • (no location specified)
Oct 10, 2021

Novel Staging Schemes for Siewert Type II Esophagogastric

Completed
  • Adenocarcinoma of the Esophagogastric Junction
  • esophagogastric junction cancer surgery
  • Fuzhou, Fujian, China
    Fujian Medical University Union Hospital
Nov 1, 2022

Proximal Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Reflux Disease Trial in Nanchong (Proximal Gastrectomy

Recruiting
  • Proximal Gastric Adenocarcinoma
  • +2 more
  • Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty
  • Nanchong, Sichuan, China
    Yunhong Tian
Aug 23, 2022

Esophageal Cancer, Gastric Cancer Trial in United States (Afatinib and Paclitaxel)

Active, not recruiting
  • Esophageal Cancer
  • Gastric Cancer
  • Afatinib and Paclitaxel
  • Los Angeles, California
  • +8 more
Mar 18, 2022

Esophagus Cancer, Esophagogastric Junction Cancer, Chemoradiation Trial in China (Radiotherapy, Platinum based chemo, Paclitaxel

Recruiting
  • Esophagus Cancer
  • +5 more
  • Radiotherapy
  • +5 more
  • Anyang, Henan, China
  • +4 more
Aug 17, 2022

Neoadjuvant Chemotherapy and Immunotherapy for HER2(-),pMMR

Recruiting
  • Gastric Cancer
  • SOX plus Paclitaxel(albumin-bound) followed by PD-1 antibody
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Sep 12, 2022

Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma Trial in Guangzhou

Recruiting
  • Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
  • Tucidinostat (chidamide) and PD-1 inhibitor （Toripalimab）
  • Guangzhou, Guangdong, China
    Cancer center of Sun Yat-sen University
Jul 20, 2022

Stomach Tumors Trial in Shanghai (Fruquintinib, Sintilimab)

Active, not recruiting
  • Stomach Neoplasms
  • Shanghai, China
    Renji Hospital
Apr 3, 2023

Esophageal Cancer, Gastric Cancer, Vitamin Disease Trial in Sittard (GIKAVI)

Recruiting
  • Esophageal Cancer
  • +3 more
  • GIKAVI
  • Sittard, Limburg, Netherlands
    ZuyderlandMC
Mar 15, 2022

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer Trial in China

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Feb 7, 2023

Carcinoma, Gastrointestinal Diseases, Stomach Cancer Trial (Anlotinib HCl capsule, Penpulimab Injection, XELOX)

Not yet recruiting
  • Carcinoma
  • +6 more
  • Anlotinib hydrochloride capsule
  • +2 more
  • (no location specified)
Aug 8, 2022

Esophagogastric Tumors, Gastric Cancer, Gastric Tumor Trial in United States (Trastuzumab, Pembrolizumab)

Recruiting
  • Esophagogastric Tumors
  • +9 more
  • Basking Ridge, New Jersey
  • +6 more
Jul 8, 2022

Esophagogastric Junction Adenocarcinoma Trial in Guangzhou (Sintilimab)

Recruiting
  • Esophagogastric Junction Adenocarcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 29, 2021

Gastric Adenocarcinoma, Esophagogastric Junction, Gastric Cancer Trial run by the National Cancer Institute (NCI) (Surgery,

Recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Surgery
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Gastric Cancer, Esophagogastric Junction Disorder Trial in Beijing (Savolitinib)

Recruiting
  • Gastric Cancer
  • Esophagogastric Junction Disorder
  • Beijing, Beijing, China
    Beijing Cancer Hopspital
Aug 30, 2021

NSCLC, Cutaneous Melanoma, Carcinoma, Renal Cell Trial (KFA115, tislelizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +10 more
  • Singapore, Singapore
    Novartis Investigative Site
Nov 16, 2022